{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:20:18Z","timestamp":1773685218788,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10067-024-07056-6","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:01:47Z","timestamp":1720800107000},"page":"2833-2842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlation between neuropsychiatric systemic lupus erythematosus and immunological markers: a real-world retrospective study"],"prefix":"10.1007","volume":"43","author":[{"given":"Yutong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-4303","authenticated-orcid":false,"given":"Zhiming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"7056_CR1","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393:2332\u20132343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5","journal-title":"Lancet"},{"key":"7056_CR2","doi-asserted-by":"publisher","unstructured":"(1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42: 599\u2013608. https:\/\/doi.org\/10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"key":"7056_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","volume":"10","author":"JG Hanly","year":"2014","unstructured":"Hanly JG (2014) Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 10:338\u2013347. https:\/\/doi.org\/10.1038\/nrrheum.2014.15","journal-title":"Nat Rev Rheumatol"},{"key":"7056_CR4","doi-asserted-by":"publisher","unstructured":"M. Govoni, S. Bombardieri, A. Bortoluzzi, L. Caniatti, C. Casu, F. Conti, S. De Vita, A. Doria, I. Farina, G. Ferraccioli, E. Gremese, E. Mansutti, M. Mosca, M. Padovan, M. Piga, A. Tincani, M. R. Tola, P. Tomietto, M. Taglietti, F. Trotta, G. Valesini, M. Zen, A. Mathieu and R. Italian Society of (2012) Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) 51: 157-68https:\/\/doi.org\/10.1093\/rheumatology\/ker310","DOI":"10.1093\/rheumatology\/ker310"},{"key":"7056_CR5","first-page":"766","volume":"28","author":"CC Mok","year":"2001","unstructured":"Mok CC, Lau CS, Wong RW (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766\u2013771","journal-title":"J Rheumatol"},{"key":"7056_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/s0002-9343(00)00603-3","volume":"109","author":"FB Karassa","year":"2000","unstructured":"Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, Moutsopoulos HM (2000) Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 109:628\u2013634. https:\/\/doi.org\/10.1016\/s0002-9343(00)00603-3","journal-title":"Am J Med"},{"key":"7056_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","volume":"43","author":"J Mikdashi","year":"2004","unstructured":"Mikdashi J, Handwerger B (2004) Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43:1555\u20131560. https:\/\/doi.org\/10.1093\/rheumatology\/keh384","journal-title":"Rheumatology (Oxford)"},{"key":"7056_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/rheumatology\/keg078","volume":"42","author":"CS Yee","year":"2003","unstructured":"Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 42:276\u2013279. https:\/\/doi.org\/10.1093\/rheumatology\/keg078","journal-title":"Rheumatology (Oxford)"},{"key":"7056_CR9","doi-asserted-by":"publisher","first-page":"e17969","DOI":"10.7759\/cureus.17969","volume":"13","author":"S Sarwar","year":"2021","unstructured":"Sarwar S, Mohamed AS, Rogers S, Sarmast ST, Kataria S, Mohamed KH, Khalid MZ, Saeeduddin MO, Shiza ST, Ahmad S, Awais A, Singh R (2021) Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus 13:e17969. https:\/\/doi.org\/10.7759\/cureus.17969","journal-title":"Cureus"},{"key":"7056_CR10","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.autrev.2021.102780","volume":"20","author":"I Carrion-Barbera","year":"2021","unstructured":"Carrion-Barbera I, Salman-Monte TC, Vilchez-Oya F, Monfort J (2021) Neuropsychiatric involvement in systemic lupus erythematosus: a review. Autoimmun Rev 20:102780. https:\/\/doi.org\/10.1016\/j.autrev.2021.102780","journal-title":"Autoimmun Rev"},{"key":"7056_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/14397595.2019.1589912","volume":"30","author":"X Li","year":"2020","unstructured":"Li X, Xiang X, Sun J, Liu S, Liu Y, Feng L, Li C, Li Z (2020) Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: a real world single center study. Mod Rheumatol 30:321\u2013326. https:\/\/doi.org\/10.1080\/14397595.2019.1589912","journal-title":"Mod Rheumatol"},{"key":"7056_CR12","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288\u2013291","journal-title":"J Rheumatol"},{"key":"7056_CR13","doi-asserted-by":"publisher","first-page":"e12849","DOI":"10.1111\/sji.12849","volume":"91","author":"Q Wei","year":"2020","unstructured":"Wei Q, Jiang Y, Xiao M, Zhang X, Qi J, Xie J, Wu J, Wu Z, Gu J (2020) Comparison of chemiluminescence microparticle immunoassay, indirect immunofluorescence assay, linear immunoassay and multiple microbead immunoassay detecting autoantibodies in systemic lupus erythematosus. Scand J Immunol 91:e12849. https:\/\/doi.org\/10.1111\/sji.12849","journal-title":"Scand J Immunol"},{"key":"7056_CR14","doi-asserted-by":"publisher","first-page":"e23546","DOI":"10.1002\/jcla.23546","volume":"34","author":"Q Wei","year":"2020","unstructured":"Wei Q, Jiang Y, Xie J, Lv Q, Xie Y, Tu L, Xiao M, Wu Z, Gu J (2020) Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases. J Clin Lab Anal 34:e23546. https:\/\/doi.org\/10.1002\/jcla.23546","journal-title":"J Clin Lab Anal"},{"key":"7056_CR15","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s10067-020-04950-7","volume":"39","author":"Q Wei","year":"2020","unstructured":"Wei Q, Jiang Y, Xie J, Yang M, Zhang Y, Wu Z, Chen S, Liao Z, Lin Z, Gu J (2020) Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases. Clin Rheumatol 39:2425\u20132432. https:\/\/doi.org\/10.1007\/s10067-020-04950-7","journal-title":"Clin Rheumatol"},{"key":"7056_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semarthrit.2020.12.004","volume":"51","author":"DA Papachristos","year":"2021","unstructured":"Papachristos DA, Oon S, Hanly JG, Nikpour M (2021) Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: a systematic review. Semin Arthritis Rheum 51:49\u201371. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.12.004","journal-title":"Semin Arthritis Rheum"},{"key":"7056_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/acr.24472","volume":"74","author":"MC Spies","year":"2022","unstructured":"Spies MC, Gutjahr-Holland JA, Bertouch JV, Sammel AM (2022) Prevalence of neuropsychiatric lupus in psychosis patients who have tested positive for antinuclear antibodies. Arthritis Care Res (Hoboken) 74:427\u2013432. https:\/\/doi.org\/10.1002\/acr.24472","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7056_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jaut.2008.12.002","volume":"32","author":"C Briani","year":"2009","unstructured":"Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S, Scarlato M, Quattrini A, Bassi N, Ermani M, Battistin L, Doria A (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32:79\u201384. https:\/\/doi.org\/10.1016\/j.jaut.2008.12.002","journal-title":"J Autoimmun"},{"key":"7056_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00296-014-3114-z","volume":"35","author":"V Pradhan","year":"2015","unstructured":"Pradhan V, Patwardhan M, Rajadhyaksha A, Dhawale N, Ghosh K (2015) Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India. Rheumatol Int 35:541\u2013545. https:\/\/doi.org\/10.1007\/s00296-014-3114-z","journal-title":"Rheumatol Int"},{"key":"7056_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/rheumatology\/41.12.1357","volume":"41","author":"R Gerli","year":"2002","unstructured":"Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, De Angelis V, Cesarotti M, Piccirilli M, Quartesan R, Moretti P, Cantoni C, Franceschini F, Cavazzana I, Origgi L, Vanoli M, Bozzolo E, Ferrario L, Padovani A, Gambini O, Vanzulli L, Croce D, Bombardieri S (2002) Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) 41:1357\u20131366. https:\/\/doi.org\/10.1093\/rheumatology\/41.12.1357","journal-title":"Rheumatology (Oxford)"},{"key":"7056_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10067-004-1060-y","volume":"24","author":"Y Shimojima","year":"2005","unstructured":"Shimojima Y, Matsuda M, Gono T, Ishii W, Ikeda S (2005) Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin Rheumatol 24:469\u2013475. https:\/\/doi.org\/10.1007\/s10067-004-1060-y","journal-title":"Clin Rheumatol"},{"key":"7056_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/0961203320908940","volume":"29","author":"G Seth","year":"2020","unstructured":"Seth G, Sundaresh A, Mariaselvam CM, Kumar G, Chengappa KG, Adarsh MB, Tamouza R, Negi VS (2020) Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India. Lupus 29:413\u2013420. https:\/\/doi.org\/10.1177\/0961203320908940","journal-title":"Lupus"},{"key":"7056_CR23","doi-asserted-by":"publisher","first-page":"920718","DOI":"10.1155\/2015\/920718","volume":"2015","author":"J Xu","year":"2015","unstructured":"Xu J, Cheng Y, Lai A, Lv Z, Campbell RA, Yu H, Luo C, Shan B, Xu L, Xu X (2015) Autoantibodies affect brain density reduction in nonneuropsychiatric systemic lupus erythematosus patients. J Immunol Res 2015:920718. https:\/\/doi.org\/10.1155\/2015\/920718","journal-title":"J Immunol Res"},{"key":"7056_CR24","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1016\/0006-2952(79)90065-0","volume":"28","author":"DT Vistica","year":"1979","unstructured":"Vistica DT, Rabon A, Rabinovitz M (1979) Cytotoxicities of the L and D isomers of phenylalanine mustard in L 1210 cells. Biochem Pharmacol 28:3221\u20133225. https:\/\/doi.org\/10.1016\/0006-2952(79)90065-0","journal-title":"Biochem Pharmacol"},{"key":"7056_CR25","doi-asserted-by":"publisher","first-page":"1323209","DOI":"10.3389\/fimmu.2024.1323209","volume":"15","author":"W Geng","year":"2024","unstructured":"Geng W, Zhang S, Cao J, Hong X, Duan Y, Jiang Y, Wei J (2024) Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus. Front Immunol 15:1323209. https:\/\/doi.org\/10.3389\/fimmu.2024.1323209","journal-title":"Front Immunol"},{"key":"7056_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08916934.2019.1696778","volume":"53","author":"GA Ramirez","year":"2020","unstructured":"Ramirez GA, Canti V, Del Rosso S, Erra R, Moiola L, Magnoni M, Bozzolo EP, Manfredi AA, Rovere-Querini P (2020) Diagnostic performance of aPS\/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus. Autoimmunity 53:21\u201327. https:\/\/doi.org\/10.1080\/08916934.2019.1696778","journal-title":"Autoimmunity"},{"key":"7056_CR27","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1007\/s00415-014-7406-8","volume":"261","author":"S Sciascia","year":"2014","unstructured":"Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G (2014) Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol 261:1706\u20131714. https:\/\/doi.org\/10.1007\/s00415-014-7406-8","journal-title":"J Neurol"},{"key":"7056_CR28","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMc1304515","volume":"368","author":"M Million","year":"2013","unstructured":"Million M, Raoult D (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368:2335. https:\/\/doi.org\/10.1056\/NEJMc1304515","journal-title":"N Engl J Med"},{"key":"7056_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/0961203316643170","volume":"25","author":"C Magro-Checa","year":"2016","unstructured":"Magro-Checa C, Schaarenburg RA, Beaart HJ, Huizinga TW, Steup-Beekman GM, Trouw LA (2016) Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 25:878\u2013888. https:\/\/doi.org\/10.1177\/0961203316643170","journal-title":"Lupus"},{"key":"7056_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.autrev.2014.11.001","volume":"14","author":"N Sarbu","year":"2015","unstructured":"Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, Yousry T, Capurro S, Jager R, Cervera R, Bargallo N (2015) Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 14:153\u2013159. https:\/\/doi.org\/10.1016\/j.autrev.2014.11.001","journal-title":"Autoimmun Rev"},{"key":"7056_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fmed.2018.00138","volume":"5","author":"JF Vivaldo","year":"2018","unstructured":"Vivaldo JF, de Amorim JC, Julio PR, de Oliveira RJ, Appenzeller S (2018) Definition of NPSLE: does the ACR nomenclature still hold? Front Med (Lausanne) 5:138. https:\/\/doi.org\/10.3389\/fmed.2018.00138","journal-title":"Front Med (Lausanne)"},{"key":"7056_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/annrheumdis-2019-216150","volume":"79","author":"JG Hanly","year":"2020","unstructured":"Hanly JG, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jonsen A, Alarcon GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Farewell V (2020) Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach. Ann Rheum Dis 79:356\u2013362. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216150","journal-title":"Ann Rheum Dis"},{"key":"7056_CR33","doi-asserted-by":"publisher","first-page":"998328","DOI":"10.3389\/fcell.2022.998328","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu Y, Tu Z, Zhang X, Du K, Xie Z, Lin Z (2022) Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: a review. Front Cell Dev Biol 10:998328. https:\/\/doi.org\/10.3389\/fcell.2022.998328","journal-title":"Front Cell Dev Biol"},{"key":"7056_CR34","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","volume":"11","author":"K Chan","year":"2020","unstructured":"Chan K, Nestor J, Huerta TS, Certain N, Moody G, Kowal C, Huerta PT, Volpe BT, Diamond B, Wollmuth LP (2020) Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory. Nat Commun 11:1403. https:\/\/doi.org\/10.1038\/s41467-020-15224-w","journal-title":"Nat Commun"},{"key":"7056_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2010.07.014","volume":"227","author":"GA Mostafa","year":"2010","unstructured":"Mostafa GA, Ibrahim DH, Shehab AA, Mohammed AK (2010) The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus. J Neuroimmunol 227:195\u2013201. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.014","journal-title":"J Neuroimmunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07056-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07056-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07056-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T20:18:06Z","timestamp":1723925886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07056-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["7056"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07056-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}